about
Tramadol for osteoarthritisProlotherapy in primary care practiceOptimal sampling of MRI slices for the assessment of knee cartilage volume for cross-sectional and longitudinal studiesCosts associated with rheumatoid arthritis in Italy: past, present, and futureDevelopment of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-projectIs early osteoarthritis associated with differences in joint congruence?Association of rs1137101 polymorphism in LEPR and susceptibility to knee osteoarthritis in a Northwest Chinese Han populationChronic back problems and labor force participation in a national population survey: impact of comorbid arthritisSoft drink intake and progression of radiographic knee osteoarthritis: data from the osteoarthritis initiativeMilk consumption and progression of medial tibiofemoral knee osteoarthritis: data from the Osteoarthritis Initiative.Validation of statistical shape modelling to predict hip osteoarthritis in females: data from two prospective cohort studies (Cohort Hip and Cohort Knee and Chingford).Utilization of elective hip and knee arthroplasty by age and payer.Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis.Radiographic assessment of the femorotibial joint of the CCLT rabbit experimental model of osteoarthritis.Quality and acceptability of measures of exercise adherence in musculoskeletal settings: a systematic review"I know I have arthritis but I don't know what type". Understanding and knowledge of this chronic condition.The prevalence and functional impact of musculoskeletal conditions amongst clients of a primary health care facility in an under-resourced area of Cape Town.Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford StudyPopulation Health Management for Older Adults: Review of Interventions for Promoting Successful Aging Across the Health Continuum.Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.Can Functional Magnetic Resonance Imaging Improve Success Rates in CNS Drug Discovery?Sleep disturbances and diminished quality of life in postural tachycardia syndrome.Reliability, construct validity and measurement potential of the ICF comprehensive core set for osteoarthritisMedical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997Efficacy of conservative treatment regimes for hip osteoarthritis--evaluation of the therapeutic exercise regime "Hip School": a protocol for a randomised, controlled trialHealth-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veteransClinically important improvement in the WOMAC and predictor factors for response to non-specific non-steroidal anti-inflammatory drugs in osteoarthritic patients: a prospective study.Exercise therapy in hip osteoarthritis--a randomized controlled trial.Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis.Meta-analysis of the association of HLA-DRB1 with rheumatoid arthritis in Chinese populationsReduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.Correlation of WOMAC and KOOS scores to tibiofemoral cartilage loss on plain radiography and 3 Tesla MRI: data from the osteoarthritis initiative.The personal and national costs of lost labour force participation due to arthritis: an economic study.Selection bias in rheumatic disease research.Degenerative musculoskeletal disease.Genetic mechanisms of knee osteoarthritis: a population based case-control study.Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxibBurden and cost of illness in patients with juvenile idiopathic arthritisTrends in hip and knee joint replacement: socioeconomic inequalities and projections of need.A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs.
P2860
Q24246129-FD97B358-A368-4493-AFF8-C0CB3DE75835Q24634136-B8DF6CDF-E612-4022-AD7D-69EF94BEBE7DQ24797792-086FA2F0-2E09-45A1-B198-25F3CC03B71FQ26765282-EA1A2A30-C720-404A-827E-6AB47BB6C516Q26998214-F322919E-B26F-4903-961A-A234029B63E7Q27310175-808555D1-1B22-4647-AF4D-27ABA0C1018FQ28384983-E732CB52-527F-4F4D-A4CF-EA30F3319D00Q28396922-611383B0-4B1A-45AF-9744-274AF060B8E2Q30656380-85EF15E2-A805-439D-AC8F-D4E5830CD345Q30794886-4DDE2452-EA08-4D98-AEE0-6F6664EC1512Q30978396-FF68D3BE-5C90-4D31-8A60-D49C467D8E0FQ33316063-15052C8C-AABE-43E2-AA91-6DB05ADC404DQ33323076-E9EB3C8C-5D01-4CE1-A210-C9BE2A476337Q33525369-2D1E2B90-B64C-4A7D-87B1-45059D67806EQ33620572-1BCC14BA-F58C-4D29-921B-F335FF877CDAQ33650442-9BF5D56F-3BC5-4704-8D64-26FD49F95B90Q33694797-E33DCDCB-6367-4F06-9DDD-2C5449793171Q33739798-CE4D3CBA-6E19-4BB7-8523-E73319ACC104Q33840491-5C4F73D7-B005-41CA-A02D-E3C1B096F21CQ33862052-C108CEB7-4A05-4C72-9ABD-8A1EB4D0D597Q33963735-0A9EDBF6-4CD5-4810-9DFF-F8A8B04C798CQ34026616-07FE2345-EC3A-4024-A5D1-ABED7D01258FQ34070033-D1E69D87-9718-4EF2-B704-04F7FE85C4F6Q34079091-83D3B83F-D479-4A1B-BC35-42A6A4ED8D4EQ34083085-B1571E99-47C7-46AF-9C1C-1335C48713D2Q34128695-13D980A7-6C5E-433A-9997-3CBBFC4474A3Q34136319-5F9CB369-B5BE-4A08-9860-EA7135FC6BC6Q34241829-C6F512B4-C225-479A-A9DE-9F9CA25377E5Q34449825-A73CDD6D-5990-4F83-A5DC-632712DBA59DQ34508209-CAD37A19-F034-4B2A-BE23-62B714D451CFQ34548071-2785D026-F276-46DB-A5CD-C36C8FCFAB39Q34556724-2F7E644F-1DB5-4C67-8E17-902A32954310Q34604509-E3E44077-590E-4414-AC0C-5C8BFF6986C8Q34662693-CFEF13BD-31BF-4194-8D72-2911649888E4Q35553236-3D5FA640-CF96-4E8C-B179-D7AC0E2543C0Q35553405-FBAA4CBB-FBE2-4E0B-BBC8-83957B08134BQ35553447-75E5DC62-B578-400C-B896-4FC7E856206CQ35554270-5416F5B2-E9CA-4B6B-8FE5-7EEABD4E1206Q35554310-F57FD969-A903-47A5-944F-25B50FE6517BQ35555469-91A35DD4-5E82-422C-9D89-731016986D86
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The prevalence and burden of arthritis.
@ast
The prevalence and burden of arthritis.
@en
The prevalence and burden of arthritis.
@nl
type
label
The prevalence and burden of arthritis.
@ast
The prevalence and burden of arthritis.
@en
The prevalence and burden of arthritis.
@nl
prefLabel
The prevalence and burden of arthritis.
@ast
The prevalence and burden of arthritis.
@en
The prevalence and burden of arthritis.
@nl
P356
P1433
P1476
The prevalence and burden of arthritis.
@en
P2093
Reginster JY
P356
10.1093/RHEUMATOLOGY/41.SUPPL_1.3
P478
P577
2002-04-01T00:00:00Z